The US is the biggest market by sales for big pharma companies, and Europe and the US have interconnected supply chains for medicines. EU medical and pharmaceutical product exports to the US ...

Norwich had asked the District Court for a judgment declaring the FDA's decision to issue tentative approval for Norwich's Abbreviated New Drug Application (ANDA) for XIFAXAN ® (rifaximin) 550 mg and ...

Pharmaceutical Executive: How is artificial intelligence shaking up the pharma marketing space? Ted Sweetser: The first top level one that everyone is paying attention to right now (because it’s the ...

“Delaying Medicare negotiation for small-molecule drugs – the most commonly used medications – is a clear giveaway to Big Pharma. It would hand drug companies four additional years to price ...

The generic segment is controlled by a few large drugmakers and generic units of large pharma companies ... by generic drugmakers like Amgen and Teva. Biosimilar versions of blockbuster drugs ...

Chicago, IL – April 16, 2025 – Today, Zacks Equity Research Equity are Dr. Reddy’s Laboratories RDY, Sandoz SDZNY and Teva Pharmaceuticals ... units of large pharma companies.

One of those proposals is a ban on direct-to-consumer (DTC) advertising for pharma companies. Pharmaceutical Executive spoke with Sonam Dubey, a partner at Beghou Consulting, about how these potential ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

The Trump administration has taken its next steps toward imposing more tariffs on key imports, launching investigations into imports of computer chips, chip making equipment and pharmaceuticals ...

Johnson & Johnson is holding its earnings outlook steady despite President Donald Trump moving decisively toward imposing tariffs on the pharmaceutical industry. The administration’s ...

Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...

Even though Indian pharma players' 30% of the export sales comes from the US, it's difficult for them to absorb the additional “tariff cost”, and continue to sell their drugs in the US market.